Qube Research & Technologies (QRT)
OCGN icon

Qube Research & Technologies (QRT)’s Ocugen OCGN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.37M Sell
2,203,407
-1,569,659
-42% -$2.39M ﹤0.01% 1834
2026
Q1 		$6.83M Buy
+3,773,066
New +$6.52M 0.01% 1508
2025
Q3 		– Sell
-194,216
Closed -$188K – 3845
2025
Q2 		$188K Buy
+194,216
New +$161K ﹤0.01% 2921
2024
Q1 		– Sell
-2,552
Closed -$1.47K – 4749
2023
Q4 		$1.47K Sell
2,552
-23,625
-90% -$9.47K ﹤0.01% 3841
2023
Q3 		$10.5K Sell
26,177
-303,885
-92% -$150K ﹤0.01% 3303
2023
Q2 		$179K Buy
+330,062
New +$212K ﹤0.01% 1808
2023
Q1 		– Sell
-51,881
Closed -$67.4K – 2878
2022
Q4 		$67.4K Sell
51,881
-133,560
-72% -$208K ﹤0.01% 2094
2022
Q3 		$330K Sell
185,441
-311,494
-63% -$775K ﹤0.01% 1604
2022
Q2 		$1.13M Buy
+496,935
New +$1.19M 0.01% 1051

Other funds holding OCGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OCGN Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Ocugen (OCGN) stake by 42% in Q2 2026, selling an estimated $2.39M and leaving 2,203,407 shares worth $3.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1834.

Qube Research & Technologies (QRT) first reported a position in OCGN in Q2 2022 and has held it in 9 quarters since. The position peaked at $6.83M in Q1 2026. 148 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Qube Research & Technologies (QRT) held 2,203,407 shares of Ocugen worth $3.37M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 1,569,659 Ocugen shares in Q2 2026, an estimated $2.39M.
  • Ocugen made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1834 holding.
  • Qube Research & Technologies (QRT) first reported a position in Ocugen in Q2 2022 and has held it in 9 quarters since.
  • Qube Research & Technologies (QRT)'s Ocugen position peaked at $6.83M in Q1 2026.
  • 148 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.